<rss version="2.0">
  <channel>
    <title>SocialPicks.com: Recent activities for JIMMY T </title>
    <link>http://www.socialpicks.com/jimmyt</link>
    <description></description>
    <language>en</language>
    <copyright>&amp;copy;2007 SocialPicks</copyright>
    <item>
      <title>TIDE HAS TURNED AND IT'S TIME TO BUY NOW! (GNBT, rated BUY)</title>
      <link>http://stockbuzz.us.reuters.com/ideas/show/199358</link>
      <description>RISK AND STOCK PRICE NOW IN FAVOR  OF LONG INVESTORS!  POTENTIAL OF 50% IN SIX MONTHS SHORT TERM IS FANTASTIC AND REWARDS COULD EVEN BE GREATER LONGER TERM.</description>
      <pubDate>Mon, 18 Aug 2008 14:07:06 -0000</pubDate>
      <author>JIMMY T </author>
      <category domain="http://rss.financialcontent.com/stocksymbol">GNBT</category>
    </item>
    <item>
      <title>MDRNA Inc. (MRNA) is a SELL</title>
      <link>http://stockbuzz.us.reuters.com/ideas/show/199085</link>
      <description>PARTNER:SHORT PERIOD OF TIME - APPROVALS: YEARS AWAY  REVENUE: YEARS AWAY IF THEY RECEIVE APPROVALS - RETURN ON EQUITY: ALMOST -80%NOW AND YEARS BEFORE IN THE BLACK ONCE AGIN, 'MAYBE'  -SEASONAL &amp; PANDEMIC FLU: THERE ARE MANY TOP COMPANIES IN THE FOREFRONT ALREADY WITH PRODUCTS ON THE MARKET!  I HAVE SAID FOR YEARS THAT THIS STOCK IS A TRADERS DELIGHT. EVEN ABOVE, SOCIAL PICKS DISPLAYS THIS SENTENCE.  "THIS IS A MICRO-CAP STOCK AND MAY BE A TARGET OF MANIPULATION."  SO FAR THE INSTITUTIONS, FUNDS AND INVESTORS HAVE RECEIVED THE 'BEATING OF THEIR LIFE FINANCIALLY WITH THIS STOCK'  THEY HAVE BEEN THE VICTIM WITH MIS-INFORMATION,  AND TOUTING WHILE MANAGEMENT BEHIND THE SCENES GETS PAY RAISES AND BONUS OPTIONS OVER AND OVER AGAIN. LETS NOT FORGET THE INSIDERS SOLD THE MOST SHARES IN 2007 JUST BEFORE ALL THE BAD NEWS SENT THIS STOCK TO BASEMENT LEVELS.  LIKE FOOLS GOLD SOME STILL INVEST AND HAVE HOPE.  FOOLS OR STUPIDITY AT THIS POINT! </description>
      <pubDate>Sat, 16 Aug 2008 21:41:05 -0000</pubDate>
      <author>JIMMY T </author>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
    </item>
    <item>
      <title>MRNA:BURDEN NOW RESTS ON MANAGEMENT (MRNA, rated SELL)</title>
      <link>http://stockbuzz.us.reuters.com/ideas/show/197405</link>
      <description>I WONDER HOW THE NEW CEO, MR.FRENCH NOW FEELS AFTER ACCEPTING THE POSITION AND BEING ASSOCIATED WITH THIS COMPANY? MRNA NOW $.75CENTS!  TO GET THIS COMPANY BACK UP TO A LEVEL OF CREDITABILITY, AND BACK IN THE FOREFRONT HAS TO BE THE BIGGEST UNDERTAKING OF MR.FRENCH'S CAREER.   I WOULDN'T BE SURPRISED IF HE RESIGNS BY YEAR END.  FINDING A PARTNER IS KEY SURVIVAL FOR MANAGEMENT. IF MR.FRENCH RESIGNS  THAT WOULD ONLY CONFIRM THAT A PARTNER COULD NOT BE HAD!</description>
      <pubDate>Sat, 09 Aug 2008 13:21:44 -0000</pubDate>
      <author>JIMMY T </author>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
    </item>
    <item>
      <title>MDRNA Inc. (MRNA) is a SELL</title>
      <link>http://stockbuzz.us.reuters.com/ideas/show/188855</link>
      <description>$1.00 bid by august 21, 2008</description>
      <pubDate>Fri, 11 Jul 2008 20:14:22 -0000</pubDate>
      <author>JIMMY T </author>
      <category domain="http://rss.financialcontent.com/stocksymbol">MRNA</category>
    </item>
    <item>
      <title>Nastech Pharmaceutical Company Inc. (NSTK) is a SELL</title>
      <link>http://stockbuzz.us.reuters.com/ideas/show/172157</link>
      <description>NSTK:HEADING FOR $1.00 BID REAL SOON!  NO MOMENTUM,NO PRODUCTS, ENIMIC VOLUME,NO PARTNERS,  NO REVENUE TO SPEAK OF, LARGE EXPENSES,  AND MANY FINANCIALLY   DECIMATED SHAREHOLDERS ALL OVER THE PLACE.  NSTK NEEDS NEW NAME, NEW SHAREHOLDERS SO MANAGEMENT CAN COLLECT SALARIES FOR ANOTHER 24 YEARS.</description>
      <pubDate>Thu, 22 May 2008 17:59:58 -0000</pubDate>
      <author>JIMMY T </author>
      <category domain="http://rss.financialcontent.com/stocksymbol">NSTK</category>
    </item>
    <item>
      <title>Generex Biotechnology Corp (GNBT) is a SELL</title>
      <link>http://stockbuzz.us.reuters.com/ideas/show/171190</link>
      <description>	
	
	
	
      &lt;!-- START OF NO ANALYSIS --&gt;
      &lt;div class="analysisBox"&gt;
        &lt;span class="smalltext"&gt;
        &lt;br/&gt;
        &lt;b&gt;&lt;u&gt;SELL&lt;/u&gt;&lt;/b&gt; 
        rating on &lt;b&gt;Generex Biotechnology Corp&lt;/b&gt; 
        (&lt;a href="/stock/GNBT"&gt;GNBT&lt;/a&gt;)
        
        &lt;br/&gt;&lt;br/&gt;
        
        &lt;span class="lightblack"&gt;Start Price:&lt;/span&gt; &amp;nbsp; $1.05
        &lt;br/&gt;
        &lt;span class="lightblack"&gt;Start Date:&lt;/span&gt; &amp;nbsp; 05/18/2008
        &lt;br/&gt;

            
        
                
        &lt;/span&gt;
      &lt;/span&gt;
      &lt;/div&gt;
      &lt;br/&gt;
      
      &lt;!-- END OF NO ANALYSIS --&gt;</description>
      <pubDate>Sun, 18 May 2008 01:38:21 -0000</pubDate>
      <author>JIMMY T </author>
      <category domain="http://rss.financialcontent.com/stocksymbol">GNBT</category>
    </item>
    <item>
      <title>XOMA Ltd. (XOMA) is a BUY</title>
      <link>http://stockbuzz.us.reuters.com/ideas/show/171189</link>
      <description>	
	
	
	
      &lt;!-- START OF NO ANALYSIS --&gt;
      &lt;div class="analysisBox"&gt;
        &lt;span class="smalltext"&gt;
        &lt;br/&gt;
        &lt;b&gt;&lt;u&gt;BUY&lt;/u&gt;&lt;/b&gt; 
        rating on &lt;b&gt;XOMA Ltd.&lt;/b&gt; 
        (&lt;a href="/stock/XOMA"&gt;XOMA&lt;/a&gt;)
        
        &lt;br/&gt;&lt;br/&gt;
        
        &lt;span class="lightblack"&gt;Start Price:&lt;/span&gt; &amp;nbsp; $2.05
        &lt;br/&gt;
        &lt;span class="lightblack"&gt;Start Date:&lt;/span&gt; &amp;nbsp; 05/18/2008
        &lt;br/&gt;

            
        
                
        &lt;/span&gt;
      &lt;/span&gt;
      &lt;/div&gt;
      &lt;br/&gt;
      
      &lt;!-- END OF NO ANALYSIS --&gt;</description>
      <pubDate>Sun, 18 May 2008 01:35:48 -0000</pubDate>
      <author>JIMMY T </author>
      <category domain="http://rss.financialcontent.com/stocksymbol">XOMA</category>
    </item>
    <item>
      <title>SAVVIS Inc. (SVVS) is a BUY</title>
      <link>http://stockbuzz.us.reuters.com/ideas/show/171188</link>
      <description>	
	
	
	
      &lt;!-- START OF NO ANALYSIS --&gt;
      &lt;div class="analysisBox"&gt;
        &lt;span class="smalltext"&gt;
        &lt;br/&gt;
        &lt;b&gt;&lt;u&gt;BUY&lt;/u&gt;&lt;/b&gt; 
        rating on &lt;b&gt;SAVVIS Inc.&lt;/b&gt; 
        (&lt;a href="/stock/SVVS"&gt;SVVS&lt;/a&gt;)
        
        &lt;br/&gt;&lt;br/&gt;
        
        &lt;span class="lightblack"&gt;Start Price:&lt;/span&gt; &amp;nbsp; $16.06
        &lt;br/&gt;
        &lt;span class="lightblack"&gt;Start Date:&lt;/span&gt; &amp;nbsp; 05/18/2008
        &lt;br/&gt;

            
        
                
        &lt;/span&gt;
      &lt;/span&gt;
      &lt;/div&gt;
      &lt;br/&gt;
      
      &lt;!-- END OF NO ANALYSIS --&gt;</description>
      <pubDate>Sun, 18 May 2008 01:35:48 -0000</pubDate>
      <author>JIMMY T </author>
      <category domain="http://rss.financialcontent.com/stocksymbol">SVVS</category>
    </item>
    <item>
      <title>Eli Lilly and Company (LLY) is a BUY</title>
      <link>http://stockbuzz.us.reuters.com/ideas/show/171187</link>
      <description>	
	
	
	
      &lt;!-- START OF NO ANALYSIS --&gt;
      &lt;div class="analysisBox"&gt;
        &lt;span class="smalltext"&gt;
        &lt;br/&gt;
        &lt;b&gt;&lt;u&gt;BUY&lt;/u&gt;&lt;/b&gt; 
        rating on &lt;b&gt;Eli Lilly and Company&lt;/b&gt; 
        (&lt;a href="/stock/LLY"&gt;LLY&lt;/a&gt;)
        
        &lt;br/&gt;&lt;br/&gt;
        
        &lt;span class="lightblack"&gt;Start Price:&lt;/span&gt; &amp;nbsp; $48.99
        &lt;br/&gt;
        &lt;span class="lightblack"&gt;Start Date:&lt;/span&gt; &amp;nbsp; 05/18/2008
        &lt;br/&gt;

            
        
                
        &lt;/span&gt;
      &lt;/span&gt;
      &lt;/div&gt;
      &lt;br/&gt;
      
      &lt;!-- END OF NO ANALYSIS --&gt;</description>
      <pubDate>Sun, 18 May 2008 01:35:47 -0000</pubDate>
      <author>JIMMY T </author>
      <category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
    </item>
    <item>
      <title>Teva Pharmaceutical Industries Ltd (TEVA) is a BUY</title>
      <link>http://stockbuzz.us.reuters.com/ideas/show/171186</link>
      <description>	
	
	
	
      &lt;!-- START OF NO ANALYSIS --&gt;
      &lt;div class="analysisBox"&gt;
        &lt;span class="smalltext"&gt;
        &lt;br/&gt;
        &lt;b&gt;&lt;u&gt;BUY&lt;/u&gt;&lt;/b&gt; 
        rating on &lt;b&gt;Teva Pharmaceutical Industries Ltd&lt;/b&gt; 
        (&lt;a href="/stock/TEVA"&gt;TEVA&lt;/a&gt;)
        
        &lt;br/&gt;&lt;br/&gt;
        
        &lt;span class="lightblack"&gt;Start Price:&lt;/span&gt; &amp;nbsp; $46.65
        &lt;br/&gt;
        &lt;span class="lightblack"&gt;Start Date:&lt;/span&gt; &amp;nbsp; 05/18/2008
        &lt;br/&gt;

            
        
                
        &lt;/span&gt;
      &lt;/span&gt;
      &lt;/div&gt;
      &lt;br/&gt;
      
      &lt;!-- END OF NO ANALYSIS --&gt;</description>
      <pubDate>Sun, 18 May 2008 01:35:47 -0000</pubDate>
      <author>JIMMY T </author>
      <category domain="http://rss.financialcontent.com/stocksymbol">TEVA</category>
    </item>
  </channel>
</rss>
